Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Safety monitoring and information (122)
- Compliance and enforcement (32)
- Import and export (28)
- Shortages and supply disruptions (17)
- Sunscreens (7)
- Advertising (6)
- COVID-19 (5)
- Labelling and packaging (4)
- Weight loss products (4)
- Breast implant hub (3)
- Manufacturing (3)
- Legislation (2)
- Metal-on-metal hip replacement implants hub (1)
Type of content
Search
1026 result(s) found, displaying 726 to 750
-
Market actionsLiko overhead lifts in chlorinated areas may have fastener corrosion, causing rails to fall. No reports in Australia, but check your lifts and contact Hill-Rom for inspection.
-
Safety alerts
-
Safety alerts
-
Safety alerts
-
Safety alerts
-
Safety alertsQuestions and answers about Dextropropoxyphene
-
Safety alertsConsumers and health professionals are advised that Smith & Nephew, in consultation with the TGA, has issued a hazard alert regarding the femoral implant component of the Journey Bi-Cruciate Stabilised (BCS) knee replacement system.
-
Safety alerts
-
Market actions
-
Safety alerts
-
Safety alertsPhen Tabz tablets are banned in Australia because they contain a hidden, dangerous chemical (DMAA) that can seriously harm your health.
-
-
Safety alerts
-
Safety alertsNew conditions for Di-Gesic and Doloxene (dextropropoxyphene) took effect on 10 October 2013 to ensure safe use, changing how these pain-killers are prescribed and supplied.
-
Market actions
-
Market actions
-
Safety alerts
-
Market actions
-
Safety alertsThe TGA has tested two samples of a product labelled Prosolution tablets and found that one counterfeit sample contained tadalafil and sildenafil.
-
Market actions
-
Market actions
-
Safety alerts
-
Safety alerts
-
Safety alertsNew conditions on Di-Gesic and Doloxene (dextropropoxyphene) will change how these pain-killers are prescribed and supplied to ensure safe use from 10 October 2023.
-
Market actionsOwners and people responsible for HeartSine PAD 300/PAD 300P public access defibrillators are advised that Aero Healthcare, in consultation with the TGA, undertook a recall for product correction of some of these devices in November 2012 to correct certain battery and software problems that may affect the ability of the device to work in the event it is needed.